Clinical Trial Detail

NCT ID NCT01896856
Title Phase I Study of SGI-110 With Irinotecan Followed by Randomized Phase II Study of SGI-110 With Irinotecan Versus Regorafenib in Previously Treated Metastatic Colorectal Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements no
Sponsors Sidney Kimmel Comprehensive Cancer Center
Indications

rectum adenocarcinoma

colon adenocarcinoma

Therapies

Guadecitabine + Irinotecan

Regorafenib

Age Groups: adult

No variant requirements are available.